Related Experiment Video
Updated: Aug 25, 2025

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
Published on: June 4, 2012
A Rare Case of Successfully Treated Double Valve Infective Endocarditis Caused by Pseudomonas aeruginosa
Raluca Tomoaia1,2,3, Alexandru Oprea4,5, Irina Sandu6
1Cardiology Department, Heart Institute "N. Stăncioiu", 400001 Cluj-Napoca, Romania.
Abstract:
Pseudomonas aeruginosa is a rare yet particularly aggressive infective endocarditis pathogen. We describe a case of successfully managed double-valve P. aeruginosa infective endocarditis, in which the presumed source of bacteremia was a long-term tunneled central venous catheter used for hemodialysis.
Insights
Pseudomonas aeruginosa is an aggressive cause of infective endocarditis. This case highlights successful management of double-valve P. aeruginosa infective endocarditis originating from a hemodialysis catheter.
Area of Science:
- Infectious Diseases
- Cardiology
- Nephrology
Background:
- Infective endocarditis (IE) is a serious infection affecting heart valves.
- Pseudomonas aeruginosa is an uncommon but virulent pathogen in IE cases.
- Long-term central venous catheters for hemodialysis are potential sources of bloodstream infections.
More Related Videos
08:34Generation of In-Frame Gene Deletion Mutants in Pseudomonas aeruginosa and Testing for Virulence Attenuation in a Simple Mouse Model of Infection
Published on: January 8, 2020
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis II: Clinical Features of Infective Endocarditis
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: